Related Experiment Video
Updated: May 17, 2026
08:05
A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
Published on: June 8, 2018
Immunologic response to tumor ablation with irreversible electroporation
1Orthopedics Oncology Institute of Chinese PLA, Tangdu Hospital, the Fourth Military Medical University, Xi'an, Shannxi, China.
Plos One
|November 10, 2012
Summary
Irreversible electroporation (IRE) effectively ablates osteosarcoma tumors and enhances cellular immunity in rats. This promising technique shows potential for future clinical applications in cancer treatment.
Area of Science:
- Oncology
- Immunology
- Biomedical Engineering
Background:
- Irreversible electroporation (IRE) is an emerging focal tissue ablation technique.
- Understanding the immune response to IRE for cancer treatment is crucial but limited.
Purpose of the Study:
- To investigate if tumor ablation using IRE in an osteosarcoma rat model triggers an immune response.
- To compare the immunologic effects of IRE with surgical resection.
Main Methods:
- An osteosarcoma rat model was established, with rats randomized into control, sham, surgical resection, and IRE groups.
- Peripheral blood T lymphocyte subsets, sIL-2R, and IL-10 levels were analyzed post-operation.
- Splenocytes were assessed for IFN-γ and IL-4 production via intracellular cytokine staining.
Main Results:
- IRE completely ablated osteosarcoma tumor cells.
- Both IRE and surgical resection increased peripheral lymphocytes (CD3+, CD4+) and the CD4+/CD8+ ratio.
- IRE demonstrated a stronger cellular immune response and increased IFN-γ production compared to surgical resection.
Conclusions:
- IRE effectively destroys tumors locally and modulates cellular immunity in osteosarcoma-bearing rats.
- These findings provide evidence supporting the clinical use of IRE for osteosarcoma treatment.
